Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2376785 | 0.89 | MEN1 (0.67) | MEN1KMT2AALDH1A1 | |
| SCHEMBL1915903 | 0.83 | MEN1 (0.70) | MEN1KMT2A | |
| SCHEMBL2378930 | 0.82 | MEN1 (0.65) | MEN1KMT2A | |
| SCHEMBL8557569 | 0.82 | MEN1 (0.86) | MEN1KMT2AALDH1A1 | |
| SCHEMBL19060661 | 0.81 | MTNR1A (0.69) | MEN1KMT2A | |
| SCHEMBL29079535 | 0.81 | AKR1B1 (0.70) | MEN1KMT2A | |
| SCHEMBL2379821 | 0.81 | KDM4E (0.65) | — | |
| SCHEMBL14432087 | 0.80 | KMT2A (0.66) | MEN1KMT2AALDH1A1 | |
| SCHEMBL2378518 | 0.80 | TRPV1 (0.68) | MEN1KMT2AALDH1A1 | |
| SCHEMBL4022887 | 0.80 | KMT2A (0.87) | MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270699-A1 | METHOD FOR MODULATING METABOLISM | Sanford Burnham Prebys Medical Discovery Institute | 2023-08-31 | — | — | US | disclosed |
| US-11382880-B2 | Method for improving digestive health | BRIGHTSEED, INC. (US) | 2022-07-12 | — | — | US | disclosed |
| US-20210128499-A1 | METHOD FOR IMPROVING DIGESTIVE HEALTH | BRIGHTSEED, INC. | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270699-A1 | METHOD FOR MODULATING METABOLISM | GOT2, GYS2, PC | MEN1 3891/4885KMT2A 2636/4885ALDH1A1 603/4885 |
| US-11382880-B2 | Method for improving digestive health | FABP6, FABP2, PNLIP | MEN1 2367/4885KMT2A 3396/4885ALDH1A1 723/4885 |
| US-20210128499-A1 | METHOD FOR IMPROVING DIGESTIVE HEALTH | FABP6, FABP2, PNLIP | MEN1 2367/4885KMT2A 3396/4885ALDH1A1 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.